Stockreport

DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837

Medpace Holdings, Inc.  (MEDP) 
Last medpace holdings, inc. earnings: 4/28 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.medpace.com
PDF Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic candidate DNV3837 in Clostridioides1 ( [Read more]